EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol

Patricia Magadán-Corpas, Álvaro Pérez-Valero iD, Suhui Ye iD, Sandra Sordon iD, Ewa Huszcza iD, Jarosław Popłoński, Claudio J Villar, Felipe Lombó iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Patricia Magadán-Corpas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Group BIONUC (Biotechnology of Nutraceuticals and Bioactive Compounds), Departamento de Biología Funcional, Área de Microbiología, Universid…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Colitis, Propiophenones. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Gobierno del Principado de Asturias, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory disorder affecting the colon, with symptomatology influenced by factors including environmental, genomic, microbial, and immunological interactions. Gut microbiota dysbiosis, characterized by bacterial population alterations, contributes to intestinal homeostasis disruption and aberrant immune system activation, thereby exacerbating the inflammatory state. This study assesses the therapeutic efficacy of intraperitoneal (IP) injected flavonoids (apigenin, luteolin, and xanthohumol) in the reduction of inflammatory parameters and the modulation of the gut microbiota in a murine model of ulcerative colitis. Flavonoids interact with gut microbiota by modulating their composition and serving as substrates for the fermentation into other anti-inflammatory bioactive compounds. Our results demonstrate the effectiveness of luteolin and xanthohumol treatment in enhancing the relative abundance of anti-inflammatory microorganisms, thereby attenuating pro-inflammatory species. Moreover, all three flavonoids exhibit efficacy in the reduction of pro-inflammatory cytokine levels, with luteolin strongly demonstrating utility in alleviating associated physical UC symptoms. This suggests that this molecule is a potential alternative or co-therapy to conventional pharmacological interventions, potentially mitigating their adverse effects. A limited impact on microbiota is observed with apigenin, and this is attributed to its solubility constraints via the chosen administration route, resulting in its accumulation in the mesentery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGastrointestinal MicrobiomeColitisPropiophenonesRatsMiceAnimalsApigeninLuteolinColonInflammationFlavonoidsAnti-Inflammatory AgentsDextran SulfateDisease Models, Animal

Stichwörter der Autor:innen

anti-inflammatoryflavonoidgut microbiotainflammatory bowel disease

Substanzen

xanthohumolApigeninLuteolinFlavonoidsAnti-Inflammatory AgentsDextran SulfatePropiophenones

Autor:innen und Institutionen

  • Research Group BIONUC (Biotechnology of Nutraceuticals and Bioactive Compounds), Departamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo, 33006 Oviedo, Spain.
  • IUOPA (Instituto Universitario de Oncología del Principado de Asturias), 33006 Oviedo, Spain.
  • ISPA (Instituto de Investigación Sanitaria del Principado de Asturias), 33006 Oviedo, Spain.
  • Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.

ORCID-Profile: Álvaro Pérez-Valero, Suhui Ye, Sandra Sordon, Ewa Huszcza, Felipe Lombó

Förderung

  • European Union
  • Gobierno del Principado de Asturias
  • Ministerio de Ciencia e Innovación
  • Principado de Asturias (Spain)
  • MICINN (Spanish Ministry of Science and Innovation)
  • European Union’s Horizon 2020 Research and Innovation Program

Zitieren

APA

Magadán-Corpas, P., Pérez-Valero, Á., Ye, S., Sordon, S., Huszcza, E., Popłoński, J., Villar, C. J., & Lombó, F. (2024). Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063236

Vancouver

Magadán-Corpas P, Pérez-Valero Á, Ye S, Sordon S, Huszcza E, Popłoński J, et al. Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063236

BibTeX
@article{MagadnCorpas2024,
  author = {Magadán-Corpas, Patricia and Pérez-Valero, Álvaro and Ye, Suhui and Sordon, Sandra and Huszcza, Ewa and Popłoński, Jarosław and Villar, Claudio J and Lombó, Felipe},
  title = {Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063236}
}
Kostenlos starten →